This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Regional enteritis and ulcerative colitis
  • /
  • The role of Nrf2 in the pathogenesis and treatment...
Journal

The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis

Read time: 1 mins
Published:5th Jun 2023
Author: Peng S, Shen L, Yu X, Zhang L, Xu K, Xia Y, et al.
Ref.:Front Immunol. 2023 Jun 5;14:1200111
DOI:10.3389/fimmu.2023.1200111
The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis


Ulcerative colitis (UC) is a chronic inflammatory bowel disease involving mainly the colorectal mucosa and submucosa, the incidence of which has been on the rise in recent years. Nuclear factor erythroid 2-related factor 2 (Nrf2), known for its key function as a transcription factor, is pivotal in inducing antioxidant stress and regulating inflammatory responses. Numerous investigations have demonstrated the involvement of the Nrf2 pathway in maintaining the development and normal function of the intestine, the development of UC, and UC-related intestinal fibrosis and carcinogenesis; meanwhile, therapeutic agents targeting the Nrf2 pathway have been widely investigated. This paper reviews the research progress of the Nrf2 signaling pathway in UC.


Read abstract on library site  Access full article